• <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
      <b id="1ykh9"><small id="1ykh9"></small></b>
    1. <b id="1ykh9"></b>

      1. <button id="1ykh9"></button>
        <video id="1ykh9"></video>
      2. west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "胸膜" 49 results
        • 開窗換藥治療全肺切除術后氣管殘端瘺伴食管胸膜瘺一例

          Release date:2016-08-30 05:47 Export PDF Favorites Scan
        • 支氣管鏡聯合消化內鏡成功治療食管癌術后氣管食管瘺和胃底胸膜瘺一例

          目的 探索氣管食管瘺及胃底胸膜瘺的臨床救治方法。方法 回顧分析我院呼吸與危重癥醫學科經支氣管鏡聯合消化內鏡成功治療食管癌術后氣管食管瘺和胃底胸膜瘺1例。結果 患者男,64歲,因“進食后胸痛3周余”于2021年6月21日入胸外科,23日胃鏡示食管中段新生物,病理為中分化鱗癌,25日行胸腔鏡下右胸腹兩切口食道癌根治術。術后第4天患者出現胸痛伴發熱,7月5日胸部CT示左側液氣胸,胸腔鏡探查術置管引流后脫機困難,10日轉入呼吸與危重癥醫學科,數字減影血管造影下介入和氣管鏡檢查明確診斷氣管食管瘺和胃底胸膜瘺,保守治療1個月效果不佳,經多學科討論后先行氣管鏡引導下氣道Y型覆膜支架植入封堵術,后行胃鏡下氬離子束凝固術燒灼+氣管食管瘺和胃底胸膜瘺鈦夾夾閉術。患者術后痰量減少,無發熱,復查CT兩肺感染和胸腔積液明顯吸收,消化道造影未見鋇餐外溢現象,患者順利脫機堵管,拔除氣切套管后康復出院,門診隨訪病情穩定。結論 食管癌術后短期內同時出現氣管食管瘺和胃底胸膜瘺,實屬罕見,救治難度較大。該患者的成功救治說明支氣管鏡聯合消化內鏡是治療氣管食管瘺和胃底胸膜瘺的有效方法,值得借鑒和推廣。

          Release date:2022-06-10 01:02 Export PDF Favorites Scan
        • 外科手術治療慢性結核性膿胸的療效分析

          目的 探討慢性結核性膿胸的治療方式。 方法 對成都市傳染病醫院2008年1月至2010年12月收治的184例慢性結核性膿胸進行分組治療:手術組89例,男52例、女37例,年齡14~66歲,在正規有效抗癆基礎上行膿胸清除+纖維板(增厚的胸膜)剝脫術,術后繼續正規抗癆治療;對照組95例,男61例、女34例,年齡15~68歲,僅采用內科正規有效抗癆治療,比較兩組治療前后的病情變化。 結果 手術組患者經過手術治療后膿胸消除,胸廓的塌陷得到遏制,多數患者可以使塌陷胸廓得到改善,肺功能均有明顯改善,生活質量得到改善;而對照組患者治療前后癥狀無明顯改善(3例治療期間退出研究),反而自覺胸悶、胸痛、氣促等癥狀多有加重,胸廓塌陷更明顯,肺功能繼續惡化,生活質量變差。治療結束后兩組病例均進行門診隨訪1~3年,手術組失訪1例,對照組失訪2例,隨訪率98.3%;隨訪期間,手術組無膿胸復發,患者癥狀體征改善,無再住院,而對照組患者癥狀體征多有加重,再住院率40.2%。 結論 外科手術是治療慢性結核性膿胸的最佳方式。

          Release date:2016-08-30 05:47 Export PDF Favorites Scan
        • 經氣管置管沖洗治療肺切除后支氣管胸膜瘺

          目的 探討經氣管置管沖洗治療肺切除術后支氣管胸膜瘺的療效。 方法 對發生支氣管胸膜瘺患者先行胸腔閉式引流 ,然后在纖維支氣管鏡下將一直徑 2 mm導管通過鼻腔經支氣管殘端瘺口置入胸腔 ,導管超過瘺口1~ 1.5 cm ,經導管向胸腔滴注生理鹽水 ,并從患側胸腔引流管充分引流。沖洗至引流液清亮 ,細菌培養陰性 ,引流管無明顯氣泡溢出時 ,停止沖洗。 結果  5例患者均獲得治愈 ,治愈時間為 4 2~ 6 0天。 結論 經氣管置管沖洗治療肺切除術后支氣管胸膜瘺可以取得滿意的療效 ,與單純胸腔沖洗的保守治療方法比較 ,治愈率明顯提高。

          Release date:2016-08-30 06:28 Export PDF Favorites Scan
        • Efficacy of different surgical procedures in treatment of primary spontaneous pneumothorax

          Objective To evaluate whether surgical intervention can be performed in initial onset of primary spontaneous pneumothorax (PSP) patients and whether pleural abrasion should be performed regularly in PSP treatment. Methods The clinical data of 326 PSP patients undergoing bullectomy or bullectomy combined with pleural abrasion (BLPA) between January 2008 and December 2013 were retrospectively reviewed. There were 267 males and 59 females, with a mean age of 24 years ranging from 20 to 31 years. Results The initial onset of PSP was in 229 patients, and recurrent PSP in 115 patients. Ten patients had postoperative PSP recurrence after a mean follow-up of 47 months ranging from 1 to 95 months. For the patients with initial onset of PSP, the recurrence rate was 3.1% (7/229), and that in patients with recurrent PSP was 2.6% (3/115, P=0.82). Compared with the bullectomy group (5.8%, 7/120), recurrence rate in the BLPA group was lower (1.3%, 3/224, P=0.02). There were no mortalities or significant complications in both groups. There was significant difference in body mass index (P=0.04), intraoperative adhesion (P<0.05), operation duration (P<0.01), number of bullae (P<0.01), and bullae location (P<0.01) between bullectomy and BLPA groups. Postoperative drainage (P<0.01), air leak (P=0.01) and extubation duration (P<0.01) were significantly lower in the bullectomy group. Total cost was significantly higher in the BLPA group (P<0.01). Conclusion Surgical intervention could provide satisfactory outcomes for PSP patients. Compared with bullectomy, BLPA has much lower recurrence rate, but with more drainage, longer drainage duration and higher cost.

          Release date:2017-12-04 10:31 Export PDF Favorites Scan
        • Evidence-based Treatment for a Patient with Malignant Pleural Mesothelioma

          Objective To formulate an evidence-based treatment plan for a patient with malignant pleural mesothelioma.Methods Based on an adequate assessment of the patient’s condition and using the principle of PICO, we searched The Cochrane Library (Issue 1, 2007), PubMed (1996 to February 2007) and EMbase (1974 to February 2007) to identify the best available clinical evidence. Results Five randomized controlled trials, 4 systematic reviews and 1 health economic evaluation were included. According to the current evidence, as well as the patient’s clinical condition and preference, 5 cycles of raltitrexed plus cisplatin were given to the patient along with thoracic drainage and other symptomatic treatment. And the follow-up after 4 months indicated that this treatment plan was appropriate for the patient. Conclusion Evidence-based approaches helped us to prepare the most appropriate chemotherapy plan for this patient and will help improve the therapeutic results for patients with malignant pleural mesothelioma.

          Release date:2016-09-07 02:12 Export PDF Favorites Scan
        • Clinical evaluation of endoscopic bronchial closure of Peripheral Bronchopleural Fistula with customized silicone plug

          ObjectiveTo explore the safety and efficacy of the treatment of peripheral bronchopleural fistula with customized silicone plug through bronchoscope. MethodsA total of 19 patients with BPF admitted to Hunan Provincial People’s Hospital from July 2017 to May 2023 were included. Detailed medical records of the patients were collected, including etiology, fistula location, treatment methods, complications, and effective rates, to assess the safety and efficacy of customized silicone plug occlusion. ResultsThe average age of the 19 patients was 61.58 years (range from 42~84 years). The fistulas were located at the right upper lobe in 8 cases, the right middle lobe in 2 cases, the right lower lobe in 2 cases, the left upper lobe in 2 cases, and the left lower lobe in 5 cases. Causes included 9 cases after pneumonectomy, 6 cases of spontaneous pneumothorax, 1 case post Microwave Ablation Therapy for lung nodule, 1 case of advanced lung cancer under radiotherapy and chemotherapy, 1 case of candidal pneumonia, and 1 case of pulmonary tuberculosis. 15 patients were successfully occluded for the first time, 1 case failed to place the plug, and 3 cases had silicone plug dislodgement within 1 week after the procedure, with a short-term effective rate of 73.68% (14 cases). A total of 40 customized silicone plugs were placed, with an average of (2.10±0.74), and the mean diameter of the plugs used was 6.4 mm, with a range of 3 to 9 mm. Fifteen patients were recruited for long-term follow-up, with a median follow-up time of 15 months (range from 1.5 to 53 months). One patient developed a new fistula on the 45th day, who was treated with a combined small Y-type single bullet-covered stent for occlusion. One patient died of severe pneumonia 3 months postoperatively, and one died of type II respiratory failure at the 30th month, both deaths were unrelated to the interventional procedure. The long-term effective rate was 68.42% (13 cases). ConclusionPlacing customized silicone plugs through bronchoscopy can rapidly and effectively occlude peripheral BPF, with satisfactory long-term outcome.

          Release date:2024-09-25 03:50 Export PDF Favorites Scan
        • 胸膜纖維板剝脫術治療慢性膿胸臨床觀察

          【摘要】目的 觀察胸膜纖維板剝脫術治療慢性膿胸的臨床療效。方法 2004年12月-2009年5月對23例慢性膿胸患者行胸膜纖維板剝脫術治療。結果 行單純胸膜纖維板剝脫術21例,胸膜纖維板剝脫加局限性胸改術2例。手術時間2.5~3.5 h,平均2.9 h;術中出血量425~870 mL,平均610.5 mL。以術中剝脫纖維板和肺復張情況作為手術效果評價標準,其中完全剝脫19例(82.6%),未能完全剝脫4例(17.4%)。患者出院時胸部X線片檢查示患側肺復張良好21例(91.3%),復張不全2例(8.7%)。結論 胸膜纖維板剝脫術是治療慢性膿胸較為理想與合理的一種手術方法。

          Release date:2016-09-08 09:31 Export PDF Favorites Scan
        • 胸腔鏡手術治療胸膜脂肪瘤一例

          Release date:2016-09-07 02:34 Export PDF Favorites Scan
        • 微創胸膜腔置管注入尿激酶治療結核性胸腔積液

          【摘要】 目的 探討微創胸膜腔置入中心靜脈導管(簡稱導管)注入尿激酶治療結核性包裹性胸腔積液(簡稱積液)的臨床價值。方法 2008年6月-2009年8月在正規抗結核治療基礎上,選取確診積液患者72例,按數字隨機法分為治療組和對照組,治療組36例經超聲引導導管置入胸膜腔并注入生理鹽水50 mL加尿激酶10萬 U,對照組36例多次穿刺抽液,比較兩組療效及積液引流量、胸膜厚度、積液吸收時間等。結果 治療組28例顯效,5例好轉,3例無效;對照組10例顯效,13例好轉,13例無效,兩組療效差異具有統計學意義(Plt;0.05)。治療組與對照組平均積液引流量分別為1 421 mL和756 mL,胸膜厚度分別為(1.9±0.4) mm和(3.7±1.2) mm,積液吸收時間分別為(13.3±1.2)d和(17.3±1.6)d,兩組間比較差異均有統計學意義(Plt;0.05)。結論 超聲引導導管置入胸膜腔并注入尿激酶治療結核性包裹性胸腔積液療效顯著,可增加引流量,減輕胸膜肥厚,改善肺功能,減少穿刺機會。

          Release date:2016-09-08 09:31 Export PDF Favorites Scan
        5 pages Previous 1 2 3 4 5 Next

        Format

        Content

      3. <xmp id="1ykh9"><source id="1ykh9"><mark id="1ykh9"></mark></source></xmp>
          <b id="1ykh9"><small id="1ykh9"></small></b>
        1. <b id="1ykh9"></b>

          1. <button id="1ykh9"></button>
            <video id="1ykh9"></video>
          2. 射丝袜